1 active trials 1 recruiting 1 disease areas
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT06429176 | Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients… | Cystic Fibrosis | Recruiting | 2026-05-14 |
Cystic Fibrosis (1)